Incoming information from the retina is channeled into two pathways in the brain's visual system: one that's responsible for ...

Nearly two million people worldwide have lost the simple ability to feel steady. Now researchers have developed an ...

The total diagnosed prevalence of Night Vision Disturbance (NVD) across the 7 Major Markets (United States, United Kingdom, Germany, France, Italy, Spain, and Japan) was estimated to be nearly 55 ...

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced positive top-line results from LYNX-2, a pivotal Phase 3 trial evaluating MR-142 (phentolamine ophthalmic solution 0.75% ...

Phentolamine Ophthalmic Solution 0.75% is currently being evaluated in two Phase 3 trials programs for the treatment of dim (mesopic) light vision disturbances (sometimes referred to as DLD) after ...

For more information on the LYNX-2 study design, refer to ClinicalTrials.gov NCT06349759. About Mesopic Vision and MR-142 (Phentolamine Ophthalmic Solution 0.75%) ...

The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist being investigated to reduce pupil size that is currently being evaluated ...

The Key Night Vision Disturbances Companies in the market include - Ocuphire Pharma/Viatris, and others. DelveInsight’s “Night Vision Disturbances Market Insights, Epidemiology, and Market ...

Anxiety, drug use, and autism can affect pupils. Vision disturbances sometimes link to mental health. Pupil changes are warning signs, not diagnoses. Consult a doctor for unexplained pupil variations.

Tinnitus, brain fog and visual disturbances are "constant companions" for Steve Gillis since his recovery from a virus in 2023. He said he sees through "a set of filters" with a black and white ...